In addition, as in other tumors, EphA2 exhibits angiogenic potential in CRC by contributing to neovascularization (16) or vasculogenic mimicry (76) in the tumor microenvironment (TME) of these tumors. This evidence concerns the gene EPHA2 and neoplasm.